Time-Resolved MR Angiography: A Primary Screening Examination of Patients with Suspected Pulmonary Embolism and Contraindications to Administration of Iodinated Contrast Material
- 1 May 2007
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 188 (5), 1246-1254
- https://doi.org/10.2214/ajr.06.0901
Abstract
OBJECTIVE. The purpose of this study was to evaluate the efficiency and reproducibility of a single-breath-hold time-resolved 3D MR angiographic technique in the diagnosis of pulmonary embolism. MATERIAL AND METHODS. Twenty-seven consecutively registered patients with clinically suspected pulmonary embolism and contraindication to administration of iodinated contrast agents underwent imaging by time-resolved 3D MR angiography at 1.5 T. Bolus timing was not required. Two reviewers independently analyzed MR angiograms for overall image quality and evidence of pulmonary embolism. Additional imaging techniques, including pulmonary embolism CT angiography, ventilation-perfusion (V/Q) lung scanning, venous duplex sonography for deep venous thrombosis, and echocardiography for right ventricular strain, and 30-day and 3-month clinical follow-up were used to confirm the MR angiographic findings. RESULTS. Image quality was sufficient for diagnosis in the cases of 98% of lobar, 92-93% of segmental, and 94-95% of all vessel parts from the main pulmonary artery though the segmental branches with excellent interobserver agreement. Findings on MR angiography were concordant with the anatomic distribution of abnormalities for all pulmonary embolism CT angiographic examinations (n = 2) and four of seven V/Q lung scans. Screening with time-resolved 3D MR angiography allowed confident exclusion or inclusion of pulmonary embolism in 96% of patients. CONCLUSION. Time-resolved 3D MR angiography provides high temporal resolution (nine phases, one phase per 3.3 seconds) and consistently yields arterial phase only images. As found with clinical follow-up, confident diagnosis of pulmonary embolism from the main pulmonary artery through the segmental branches can be incorporated into a clinical service as a screening examination of patients with contraindications to the use of iodinated contrast material.Keywords
This publication has 18 references indexed in Scilit:
- Sonographic Features of Abdominal Wall EndometriomaAmerican Journal of Roentgenology, 2006
- Acute adverse reactions to magnetic resonance contrast media – gadolinium chelatesThe British Journal of Radiology, 2006
- Multi–Detector Row CT Angiography of Pulmonary Circulation with Gadolinium-based Contrast Agents: Prospective Evaluation in 60 PatientsRadiology, 2006
- Anaphylactoid reactions to radiocontrast mediaCurrent Allergy and Asthma Reports, 2005
- Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective studyThe Lancet, 2002
- Acute Pulmonary Embolism: Diagnosis with MR AngiographyRadiology, 1999
- Diagnosis of Pulmonary Embolism with Magnetic Resonance AngiographyThe New England Journal of Medicine, 1997
- Clinical safety of gadopentetate dimeglumine.Radiology, 1995
- Safety of gadolinium‐DTPA: Extended clinical experienceMagnetic Resonance in Medicine, 1991
- Value of the Ventilation/Perfusion Scan in Acute Pulmonary EmbolismJama-Journal Of The American Medical Association, 1990